Yilang Chen

Title: Yilang Chen: Innovator in Pharmaceutical Compounds

Introduction

Yilang Chen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating various diseases. With a total of 3 patents to his name, Chen's work is paving the way for advancements in medical treatments.

Latest Patents

Chen's latest patents include innovative compounds and methods that address critical health issues. One of his notable inventions is an aromatic compound and its preparation method, which is aimed at treating nervous system diseases. This patent details a compound represented by a specific general formula, along with its various forms and pharmaceutically acceptable salts.

Another significant patent involves hexahydropyrrolo[3,4-b]pyrrole derivatives. This invention provides methods for preparing these derivatives, which serve as dipeptidyl peptidase IV inhibitors. These compounds are particularly useful in treating or preventing diseases associated with dipeptidyl peptidase IV, such as diabetes, obesity, and hyperlipidemia.

Career Highlights

Throughout his career, Yilang Chen has worked with notable companies in the pharmaceutical sector. He has been associated with Shanghai Sun-sail Pharmaceutical Science & Technology Co., Ltd. and Shanghai Zhigen Pharmaceutical & Technology Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Chen has collaborated with various professionals in his field, including his coworker Tao Xue. These partnerships have facilitated the exchange of ideas and advancements in their respective research areas.

Conclusion

Yilang Chen's contributions to pharmaceutical innovations are noteworthy, with his patents reflecting a commitment to improving health outcomes. His work continues to influence the development of effective treatments for various diseases.